Search Results - "Luo, Lusong"
-
1
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
Published in Journal of medicinal chemistry (12-09-2019)“…Aberrant activation of Bruton’s tyrosine kinase (BTK) plays an important role in pathogenesis of B-cell lymphomas, suggesting that inhibition of BTK is useful…”
Get full text
Journal Article -
2
Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia
Published in The Journal of pharmacology and experimental therapeutics (01-12-2017)“…Decreased erythropoietin (EPO) production, shortened erythrocyte survival, and other factors reducing the response to EPO contribute to anemia in patients who…”
Get more information
Journal Article -
3
Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor
Published in Biochemical and biophysical research communications (11-03-2011)“…► Epigallocatechin-3-gallate (EGCG) is an ATP-competitive inhibitor of PI3K and mTOR with Ki values around 300nM. ► EGCG inhibits cell proliferation and AKT…”
Get full text
Journal Article -
4
BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers
Published in Molecular cancer therapeutics (01-10-2015)“…Oncogenic BRAF, which drives cell transformation and proliferation, has been detected in approximately 50% of human malignant melanomas and 5% to 15% of…”
Get full text
Journal Article -
5
RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K‐RAS mutant tumors
Published in Molecular oncology (01-08-2020)“…The mutation of K‐RAS represents one of the most frequent genetic alterations in cancer. Targeting of downstream effectors of RAS, including of MEK and ERK,…”
Get full text
Journal Article -
6
Discovery of a potent hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis
Published in Journal of pharmacological sciences (01-07-2018)“…Aberrant activation of Hedgehog (Hh) signaling is associated with the development of numerous human cancers. Vismodegib is the first Hh inhibitor approved for…”
Get full text
Journal Article -
7
Mechanism of Inhibition of Human KSP by Ispinesib
Published in Biochemistry (Easton) (18-03-2008)“…KSP, also known as HsEg5, is a kinesin that plays an essential role in the formation of a bipolar mitotic spindle and is required for cell cycle progression…”
Get full text
Journal Article -
8
Novel ATP-Competitive Kinesin Spindle Protein Inhibitors
Published in Journal of medicinal chemistry (04-10-2007)“…Kinesin spindle protein (KSP), an ATPase responsible for spindle pole separation during mitosis that is present only in proliferating cells, has become a novel…”
Get full text
Journal Article -
9
Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295
Published in ACS medicinal chemistry letters (08-04-2010)“…Inhibition of mitotic kinesins represents a novel approach for the discovery of a new generation of anti-mitotic cancer chemotherapeutics. We report here the…”
Get full text
Journal Article -
10
Timing of Epimerization and Condensation Reactions in Nonribosomal Peptide Assembly Lines: Kinetic Analysis of Phenylalanine Activating Elongation Modules of Tyrocidine Synthetase B
Published in Biochemistry (Easton) (23-07-2002)“…The cyclic decapeptide antibiotic tyrocidine has d-Phe residues at positions 1 and 4, produced during peptide chain growth from l-Phe residues by 50 kDa…”
Get full text
Journal Article -
11
Abstract 1298: CD40L-CD40 signaling on B-cell lymphoma response to BTK inhibitors
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract The aberrant activation of B cells receptor (BCR) signaling plays an essential role in the pathogenesis of B-cell lymphomas. Targeting BCR signaling…”
Get full text
Journal Article -
12
Abstract C62: Identification of GSK2126458, a highly potent inhibitor of phosphoinositide 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR)
Published in Molecular cancer therapeutics (10-12-2009)“…Abstract Phosphoinositide 3-kinase (PI3K) is a critical regulator of cell growth and transformation and its signaling pathway is one of the most commonly…”
Get full text
Journal Article -
13
BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition
Published in Cancer cell (14-09-2015)“…ERK signaling requires RAS-induced RAF dimerization and is limited by feedback. Activated BRAF mutants evade feedback inhibition of RAS by either of two…”
Get full text
Journal Article -
14
C-Methyltransferase and Cyclization Domain Activity at the Intraprotein PK/NRP Switch Point of Yersiniabactin Synthetase
Published in Journal of the American Chemical Society (29-08-2001)Get full text
Journal Article -
15
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors
Published in Journal of clinical oncology (01-07-2020)“…Lifirafenib is an investigational, reversible inhibitor of B-RAF , wild-type A-RAF, B-RAF, C-RAF, and EGFR. This first-in-human, phase I,…”
Get full text
Journal Article -
16
Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays
Published in European journal of medicinal chemistry (15-07-2018)“…The Hedgehog (Hh) signaling pathway plays a critical role in controlling patterning, growth and cell migration during embryonic development. Aberrant…”
Get full text
Journal Article -
17
Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development
Published in Journal of medicinal chemistry (24-12-2020)“…Poly (ADP-ribose) polymerase (PARP) plays a significant role in DNA repair responses; therefore, this enzyme is targeted by PARP inhibitors in cancer therapy…”
Get full text
Journal Article -
18
Abstract 5496: Effect of BTK inhibitors on differentiation of human monocyte-derived dendritic cells
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Abstract Dendritic cells (DCs) are primary antigen-presenting cells (APCs), which process tumor antigen and present it on the cell surface to the T cells of…”
Get full text
Journal Article -
19
Modulating Electron Density in the Bound Product, 4-Hydroxybenzoyl-CoA, by Mutations in 4-Chlorobenzoyl-CoA Dehalogenase Near the 4-Hydroxy Group
Published in Biochemistry (Easton) (30-03-1999)“…The enzyme 4-chlorobenzoyl-CoA dehalogenase hydrolyzes 4-chlorobenzoyl-CoA (4-CBA-CoA) to 4-hydroxybenzoyl-CoA (4-HBA-CoA). Biochemical and crystallographic…”
Get full text
Journal Article -
20
Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity
Published in European journal of medicinal chemistry (01-11-2020)“…The chemokine receptor CXCR4 has been proposed as a drug target based on its important functions in HIV infection, inflammation/autoimmune diseases and cancer…”
Get full text
Journal Article